Cargando…

Distributed automated manufacturing of pluripotent stem cell products

Establishing how to effectively manufacture cell therapies is an industry-level problem. Decentralised manufacturing is of increasing importance, and its challenges are recognised by healthcare regulators with deviations and comparability issues receiving specific attention from them. This paper is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shariatzadeh, Maryam, Chandra, Amit, Wilson, Samantha L, McCall, Mark J, Morizur, Lise, Lesueur, Léa, Chose, Olivier, Gepp, Michael M., Schulz, André, Neubauer, Julia C., Zimmermann, Heiko, Abranches, Elsa, Man, Jennifer, O’Shea, Orla, Stacey, Glyn, Hewitt, Zoe, Williams, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954896/ https://www.ncbi.nlm.nih.gov/pubmed/31983799 http://dx.doi.org/10.1007/s00170-019-04516-1

Ejemplares similares

Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions
por: Regent, Florian, et al.
Publicado: (2019)

The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles
por: Jarrige, Margot, et al.
Publicado: (2021)

Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development
por: Stacey, Glyn N., et al.
Publicado: (2022)

Tyramine‐conjugated alginate hydrogels as a platform for bioactive scaffolds
por: Schulz, André, et al.
Publicado: (2018)

The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors
por: Bayley, Rachel, et al.
Publicado: (2017)

Biobanking of human pluripotent stem cells in China
por: Stacey, Glyn Nigel, et al.
Publicado: (2022)

Comparability of automated human induced pluripotent stem cell culture: a pilot study
por: Archibald, Peter R. T., et al.
Publicado: (2016)

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015
por: Williams, David J, et al.
Publicado: (2016)

Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives
por: Jo, Hye-Yeong, et al.
Publicado: (2020)

Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform
por: Stacey, GN, et al.
Publicado: (2019)

Poly(amidoamine)-alginate hydrogels: directing the behavior of mesenchymal stem cells with charged hydrogel surfaces
por: Schulz, André, et al.
Publicado: (2018)

Translating stem cell research into development of cellular drugs—a perspective from manufacture of stem cell products and CMC considerations
por: Zhang, Yu Alex, et al.
Publicado: (2022)

Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
por: Kim, Jung-Hyun, et al.
Publicado: (2022)

FLDID: Federated Learning Enabled Deep Intrusion Detection in Smart Manufacturing Industries
por: Verma, Priyanka, et al.
Publicado: (2022)

History and current status of clinical studies using human pluripotent stem cells
por: Kobold, Sabine, et al.
Publicado: (2023)

End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
por: Pandey, Puspa R., et al.
Publicado: (2019)

hPSCreg—the human pluripotent stem cell registry
por: Seltmann, Stefanie, et al.
Publicado: (2016)

Understanding cell culture dynamics: a tool for defining protocol parameters for improved processes and efficient manufacturing using human embryonic stem cells
por: Kusena, J.W.T., et al.
Publicado: (2021)

Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
por: Sun, Yun, et al.
Publicado: (2021)

The isochromosome 20q abnormality of pluripotent cells interrupts germ layer differentiation
por: Vitillo, Loriana, et al.
Publicado: (2023)

Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed‐Stock Banking of Human Pluripotent Stem Cells
por: Kim, Jung‐Hyun, et al.
Publicado: (2017)

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2016)

Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2020)

Age-related neurogenesis decline in the subventricular zone is associated with specific cell cycle regulation changes in activated neural stem cells
por: Daynac, Mathieu, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3 Inhibition Enhances Translation of Pluripotency-Associated Transcription Factors to Contribute to Maintenance of Mouse Embryonic Stem Cell Self-Renewal
por: Sanchez-Ripoll, Yolanda, et al.
Publicado: (2013)

Neural Differentiation of Embryonic Stem Cells In Vitro: A Road Map to Neurogenesis in the Embryo
por: Abranches, Elsa, et al.
Publicado: (2009)

Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice‐Manufactured Human Induced Pluripotent Stem Cell Line
por: Zhu, Jie, et al.
Publicado: (2017)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

Generation and Characterization of a Novel Mouse Embryonic Stem Cell Line with a Dynamic Reporter of Nanog Expression
por: Abranches, Elsa, et al.
Publicado: (2013)

E2F1 Mediated Apoptosis Induced by the DNA Damage Response Is Blocked by EBV Nuclear Antigen 3C in Lymphoblastoid Cells
por: Saha, Abhik, et al.
Publicado: (2012)

Syndecan-1 Stimulates Adult Neurogenesis in the Mouse Ventricular-Subventricular Zone after Injury
por: Mouthon, Marc-André, et al.
Publicado: (2020)

A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
por: Lin, Haishuang, et al.
Publicado: (2018)

Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells
por: Lin, Haishuang, et al.
Publicado: (2018)

Distinct Molecular Signatures of Quiescent and Activated Adult Neural Stem Cells Reveal Specific Interactions with Their Microenvironment
por: Morizur, Lise, et al.
Publicado: (2018)

An apicosome initiates self-organizing morphogenesis of human pluripotent stem cells
por: Taniguchi, Kenichiro, et al.
Publicado: (2017)

Is Scarlatina a Bovine Malady?
por: McCall,
Publicado: (1893)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic
por: Colter, James, et al.
Publicado: (2021)

Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells
por: Manzini, Paolo, et al.
Publicado: (2022)

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatment
por: Tan, Lay Shuen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jlgslsgbkphh80b3tco37e37tv